Dartmouth Health Continuing Education for Professionals Home, Medicine Grand Rounds - Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19: Science Update, March 20, 2020, 3/20/2020 8:00:00 AM - 3/20/2023 9:00:00 AM, Dr. Talbot reviews the timeline of the COVID-19 virus from its initial outbreak in China through March 20, 2020, including the transmissibility percentages and likely incubation period. She explains that the virus is spread primarily through droplets, can survive for several hours and possibly days on fomite or inanimate objects, but can be eliminated with effective household cleaning solutions. She discusses presenting symptoms as well as blood chemistry and imaging changes, and the severity risk for certain age groups and those with pre-existing conditions. She discusses combination drug treatments that are being studied in patients for potential effective mitigation. She reviews strategies for testing and control, and the challenges that will define the local and global scope of the pandemic.
Presenters
• Elizabeth A. Talbot, MD
Professor of Medicine
Geisel School of Medicine at Dartmouth
Section of Infectious Disease & International Health, Dartmouth-Hitchcock Medical Center
Deputy State Epidemiologist, New Hampshire Department of Health and Human Services
About our presenter:
Dr. Talbot has had extensive experience in international and domestic infectious disease control through outbreak investigations, clinical projects, research, and consultation. She trained at Duke University and with the CDC's Epidemic Intelligence Service, then was stationed in Botswana and was seconded to the World Health Organization for SARS-CoV-1 response before coming to Dartmouth.
• Antonia L. Altomare, DO, MPH
Assistant Professor of Medicine
Geisel School of Medicine at Dartmouth
Section of Infectious Disease & International Health
Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center
Program Director for the Ryan White Part D HIV Program
About our presenter:
Dr. Altomare completed her medical education at the New York College of Osteopathic Medicine and residencies in Internal Medicine and Preventive Medicine, as well as a fellowship in Infectious Diseases at DHMC. She has a Masters of Public Health from the Dartmouth Institute for Health Policy & Clinical Practice. Her primary interests are quality improvement within infection control and HIV care, and she treats general infectious diseases and infections in immunocompromised hosts, with an interest in HIV.
Learning Outcome(s)
Participants will be able to review the principle clinical features which define scleroderma, discuss the impact of new therapies on the current management of scleroderma and outline the future pipeline of scleroderma therapies.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19: Science Update, March 20, 2020 (Medicine Grand Rounds) have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
Presenters
• Elizabeth A. Talbot, MD
Professor of Medicine
Geisel School of Medicine at Dartmouth
Section of Infectious Disease & International Health, Dartmouth-Hitchcock Medical Center
Deputy State Epidemiologist, New Hampshire Department of Health and Human Services
About our presenter:
Dr. Talbot has had extensive experience in international and domestic infectious disease control through outbreak investigations, clinical projects, research, and consultation. She trained at Duke University and with the CDC's Epidemic Intelligence Service, then was stationed in Botswana and was seconded to the World Health Organization for SARS-CoV-1 response before coming to Dartmouth.
• Antonia L. Altomare, DO, MPH
Assistant Professor of Medicine
Geisel School of Medicine at Dartmouth
Section of Infectious Disease & International Health
Hospital Epidemiologist, Dartmouth-Hitchcock Medical Center
Program Director for the Ryan White Part D HIV Program
About our presenter:
Dr. Altomare completed her medical education at the New York College of Osteopathic Medicine and residencies in Internal Medicine and Preventive Medicine, as well as a fellowship in Infectious Diseases at DHMC. She has a Masters of Public Health from the Dartmouth Institute for Health Policy & Clinical Practice. Her primary interests are quality improvement within infection control and HIV care, and she treats general infectious diseases and infections in immunocompromised hosts, with an interest in HIV.
Learning Outcome(s)
Participants will be able to review the principle clinical features which define scleroderma, discuss the impact of new therapies on the current management of scleroderma and outline the future pipeline of scleroderma therapies.
Disclosure
In accordance with the disclosure policy of Dartmouth-Hitchcock/Geisel School of Medicine at Dartmouth as well as standards set forth by the Accreditation Council on Continuing Medical Education and the Nursing Continuing Education Council standards set forth by the American Nurses Credentialing Center Commission on Accreditation, continuing medical education and nursing education activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content have been asked to disclose any financial relationship* they have to a commercial interest (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients). Such disclosure is not intended to suggest or condone bias in any presentation, but is elicited to provide participants with information that might be of potential importance to their evaluation of a given activity.
The following Activity Physician Director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for Severe Acute Respiratory Syndrome Coronavirus 2 COVID-19: Science Update, March 20, 2020 (Medicine Grand Rounds) have reported the following financial interest or relationship* with various companies/organizations. The Activity Director and Planning Committee member roles were resolved by altering the individual’s control over content about the products or services of the commercial interest by the Associate Dean for CME and the Department of Medicine Chair. All potential conflict(s) were resolved.
* Kelly Kieffer, MD ~ her spouse is a consultant for OcculoBio.
* Richard I. Rothstein, MD ~ has research support from Baranova (research grant to Dartmouth-Hitchcock Medical Center) and is on the Scientific Advisory Board for Allurion.
Other planning committee member(s), speaker(s), activity director(s), author(s) or anyone in a position to control the content for this program report no financial interest or relationship* with any company(ies) or organizations whose product may be germane to the content of their presentations.
*A “financial interest or relationship" refers to an equity position, receipt of royalties, consultantship, funding by a research grant, receiving honoraria for educational services elsewhere, or to any other relationship to a company that provides sufficient reason for disclosure, in keeping with the spirit of the stated policy.
